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Fructose is a sugar present in sucrose, high-fructose corn syrup, honey, and fruits. Fructose intake has increased markedly in
the last two centuries, primarily due to increased intake of added sugars. Increasing evidence suggests that the excessive intake
of fructose may induce fatty liver, insulin resistance, dyslipidemia, hypertension, and kidney disease. These studies suggest that
excessive intake of fructose might have an etiologic role in the epidemic of obesity, diabetes, and cardiorenal disease.
1.Introduction
Fructose is a monosaccharide that is widely available in
natural food sources such as fruits and honey. However, in
most countries the main source of fructose is from sucrose,
a disaccharide composed of equal portions of fructose and
glucose.IntheUnitedStatesanothermajorsourceoffructose
is high-fructose corn syrup (HFCS), which is a commercial
liquid product consisting of fructose and glucose in varying
proportions, but which in soft drinks is usually 55% fructose
and 45% glucose.
Fructose intake has increased markedly over the last 2
centuries, primarily due to the increasing intake of sucrose
and HFCS [1–3]. In particular, the introduction of HFCS in
the 1970s resulted in an accelerated intake of added sugars
in the USA, in part because HFCS was inexpensive and
could be easily mixed in with processed foods [4]. It has
been suggested that the increase in added sugars worldwide
may partially explain the marked increase in frequency of
overweightandobesehumansandmayexplaintherisingfre-
quency of metabolic syndrome, diabetes, hypertension, and
cardiovascular diseases (coronary artery disease, congestive
heart failure, stroke, and chronic kidney disease) [1–3].
Fructose is absorbed into the intestine enterocyte by the
Glut-5 speciﬁc transporter. While some fructose is metab-
olized in the small intestinal wall, much of it is passed via
the portal vein to the liver, with perhaps 20 to 30% escaping
into the systemic circulation [5, 6]. Within the hepatocyte,
fructose is phosphorylated to fructose-1-phosphate by fruc-
tokinase. Because this reaction has no negative feedback
system, if suﬃcient fructose is present, intracellular phos-
phate and ATP depletion can transiently occur. This results
in the generation of AMP which is metabolized by AMP
deaminase to inosine monophosphate and eventually to uric
acid [5]. The transient ATP depletion has some similarities
to ischemia and can result in arrest of protein synthesis with
the induction of oxidative stress and inﬂammation [7–9].
Circulating fructose is taken up by a variety of cell types,
including endothelial cells, but also is excreted into the urine
where it is absorbed via the Glut-5 transporter into the
S3 segment of the proximal tubule. This cell also expresses
fructokinase; as such, the metabolism of fructose by this
proximal tubular cell can also lead to local oxidative stress
and inﬂammation [8, 10].
2.Biological Effects ofFructose
2.1. Liver Eﬀects: Fatty Liver and Glycogen Accumulation.
Fructose is known to stimulate fat accumulation in the
liver by both increasing synthesis and blocking fat oxidation
[11, 12]. These eﬀects are independent of energy intake
[12–14].Perhapsnotsurprisingly,clinicalstudieshavelinked2 International Journal of Nephrology
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Figure 1:Proposedpathogenesisoffructose-inducedhypertension.
the intake of excessive fructose with the development of
nonalcoholic fatty liver disease in humans, and the amount
of fructose ingested correlates with the risk for progression
to cirrhosis [15, 16].
Fructose is also known to stimulate glycogen accumu-
lation in the liver [17, 18], which primarily appears to be
duetoinhibitingglycogenolysisduetoinhibitionofglycogen
phosphorylase [19].
2.2. Insulin Resistance and Islet Dysfunction. Fructose intake
has been shown to induce insulin resistance in rats [20, 21];
fructose can also induce insulin resistance in humans [22].
The proposed mechanisms are complex but may include a
consequence of hepatic lipid deposition, with diacylglycerol
accumulation leading to activation of protein kinase [22, 23]
or via the hepatic stimulation of PGC-1β [24]. Some of the
eﬀects may also be due to fructose-induced hyperuricemia
with eﬀects on endothelial and adipocyte function [14, 25].
However, the lowering of uric acid with allopurinol did not
prevent the development of insulin resistance in subjects
administered large doses (200g/d for two weeks) of fructose
[26].
Fructose intake may also accelerate the development
of type 2 diabetes in rats, possibly by accelerating islet
dysfunction via induction of mild islet inﬂammation and
oxidative stress [12, 27]. One study suggests that this might
be duein part to theeﬀectsof systemic uric acid that increase
in response to fructose (or sucrose) ingestion [12].
Fructose may also stimulate the production of advanced
glycation end products (AGEs) that have been shown to be
toxic in diabetes [28]. Indeed, chronic fructose ingestion has
been associated with the accelerated formation of cataracts
in diabetic rats [29].
Intake of sugary soft drinks has also been associated
with the development of obesity and diabetes. [30, 31]
Indeed, a recent meta-analysis by Malik et al. found a
strong independent relationship between the intake of sugar-
containing soft drinks with the subsequent development of
diabetes [32].
2.3. Obesity. Fructose does not acutely stimulate leptin or
insulin release and hence may not trigger normal satiety
responses [33]. In addition, added sugars such as sucrose
have been found to trigger dopamine responses in the
ventral and dorsal striatum, which chronically may lead to
downregulation of the D2 receptors and sugar bingeing [34].
Fructose intake can also induce a central leptin resistance in
rats, leading to increased food intake and the development
of visceral obesity [35]. Interestingly, rats on a high-fructose
diet may not show an increase in overall body weight unless
it is associated with diets high in fat [36].
2.4. Hypertension and Vascular Eﬀects. Fructose intake from
added sugars is also associated with elevated blood pressure
in humans [37], and diets low in added sugar have been
reported to lower blood pressure [38]. Furthermore, the
acute ingestion of fructose (60g) can increase systolic blood
pressure in humans, and this is not seen in subjects given
the same dose as glucose [39]. In addition, in one study,
overweight men were administered 200g fructose daily for
two weeks and sustained a signiﬁcant increase in ambulatory
blood pressure [26].
Studies in experimental animals have conﬁrmed that
fructose can raise blood pressure. Interestingly, the increase
in blood pressure in response to fructose is better observed
bytailcuﬀmeasurementasopposedtointra-aortictelemetry
[40,41].However,bloodpressurerisesinresponsetosucrose
or fructose diet by telemetry during the ﬁrst hours of feeding
[12, 42].
The mechanism of hypertension in response to fruc-
tose is complex but appears to be mediated by increased
sodium absorption in the intestine, by inhibition of systemic
endothelial function, and by stimulation of the sympathetic
nervous system [14, 43, 44]( Figure 1). In addition, some of
the eﬀect of fructose to increase blood pressure may be the
consequence of fructose-induced increases in intracellular
and serum uric acid. First, fructose-induced hypertension
in rats is largely ameliorated by lowering uric acid levels
[40]. Second, in one study in overweight men, the rise
in ambulatory blood pressure in response to 200g of oral
fructose per day for two weeks was blocked in those subjects
concomitantly administered allopurinol [26].
2.5. Kidney Disease. Fructose and sucrose are also known
to induce renal hypertrophy and tubulointerstitial disease
in rats [10, 45, 46]. The mechanism may involve two
c e n t r a lp a t h w a y s( Figure 2). First, the rise in uric acid in
response to uric acid may cause an aﬀerent arteriolopathy
resulting in glomerular hypertension [40]. Second, fructose
may also be ﬁltered into the urine where it is taken up
in the S3 segment of the proximal tubule, leading to local
intracellular generation of uric acid with oxidative stress and
local inﬂammation [8].
The administration of fructose to rats with reduced renal
function (the remnant kidney model) can accelerate the
progression of renal disease, resulting in worse proteinuria,
glomerulosclerosis, and tubulointerstitial ﬁbrosis [47]. Fruc-
tose intake also impairs calcium absorption and reduces
25-OH Vitamin D and 1,25-dihydroxy Vitamin D levels
in this model [48]. Furthermore, the intake of sugary soft
drinks in humans is associated with increased prevalence of
albuminuria [49]. Our group has also recently administered
a low-fructose diet to subjects with stable chronic kidney
disease for a period of 6 weeks. While we observed no eﬀect
on renal function during the period of the study, we didInternational Journal of Nephrology 3
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Figure 2: Mechanisms of kidney dysfunction in fructose-induced hypertension.
observe a reduction in inﬂammatory markers and a fall in
blood pressure in subjects with the “dipper” physiology (i.e.,
those subjects whose blood pressure spontaneously falls at
night during sleep) [49]. Clearly further studies are needed
to determine if limiting added sugars may beneﬁt subjects
with kidney disease.
2.6. Role of Natural Fruits. While much work has focused
on fructose as driving obesity, insulin resistance, and car-
diorenal disease, not all fructose sources may be the same.
Thus, natural fruits also are rich in antioxidants, ascorbate,
polyphenols, potassium, and ﬁber that may counter the
eﬀects of fructose [13, 50]. Indeed, Forman et al. [51]
reported that fructose intake did not correlate with elevated
bloodpressureinapopulationinwhichmuchofthefructose
intake was from fruit, whereas Jalal et al. [37]f o u n das t r o n g
association of fructose intake with blood pressure when the
fructose content from natural fruits was excluded.
2.7. Caveats. While there is increasing evidence for a role for
fructose as a contributory factor to obesity and metabolic
syndrome, most of the data has relied on epidemiological
studies, experimental models, and cell culture. In contrast,
studies in which fructose or sucrose is administered to
subjects have shown variable eﬀects on metabolic param-
eters. In general, few metabolic eﬀects are observed with
fructose when it is given to young, healthy, and lean subjects
[52–54]. This contrasts with studies in overweight/obese or
insulin-resistant subjects in which metabolic eﬀects from
fructose or sucrose are commonly observed [22, 26, 55–58].
One potential explanation may relate to the absorption of
fructose, which is known to increase with fructose exposure
[59, 60]. Fructose eﬀects are also potentiated by glucose
[61,62],andmoststudieshaveonlyexaminedfructosealone.
Most studies also show, both in animals and humans, that
the eﬀects of fructose are greater on postprandial lipids, fatty
liver, and insulin resistance rather than on weight gain per
se. Indeed, the eﬀects of fructose may be more on inducing
leptin resistance, and it may require the addition of high-fat
diet to show the weight gain [35]. More studies are necessary
before ﬁrm conclusions can be made. Nevertheless, the
evidence that excessive intake of fructose may have multiple
adverse eﬀects on human health seems to be mounting.
3. Conclusions
There are likely multiple mechanisms driving the current
epidemicofobesity,diabetes,andcardiorenaldisease.Recent
studies suggest that excessive fructose intake may be one of
the causes. Future studies should investigate the eﬀect of re-
ducing fructose intake or blocking the metabolic eﬀects of
fructose as a means for preventing or treating these im-
portant diseases.
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